Clinical Trial Update: Ventavis® Registry Protocol

View source ↗

Summary

Actelion provides an updated Ventavis Registry Protocol for pulmonary arterial hypertension. The registry study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Status: TERMINATED